Agouron Pharmaceuticals, which last month completed a...
- Share via
Agouron Pharmaceuticals, which last month completed a $5-million private stock sale to an investor group led by New York-based Alan Patricof Assoc., has sold $2 million more in stock to Burr, Egan, Deleage & Co., a Boston-based investment firm.
Agouron reported an $845,800 net loss for the first quarter ended Sept. 30, contrasted with a $532,000 net loss during the like period a year ago. Revenue rose to $532,000, up from $171,600 a year ago.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
